Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aqueous humour concentrations after topical levofloxacin + dexamethasone vs single components in cataract surgery patients
2018-001149-15Phase 2Completed
- Sponsor
- NTC Pharma
- Start
- Jul 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in cataract and well-being comparing Fixed combination levofloxacin + dexamethasone eye drops, Levofloxacin eye drops alone and Dexamethasone eye drops alone (3 arms). Primary endpoints: Aqueous humour concentration of levofloxacin, Aqueous humour concentration of dexamethasone 21-phosphate and 1 more. Started Jul 2020; status: completed.
02
Drugs
levofloxacindexamethasone
03
Conditions
cataractwell-being
Beyond the preview
Go deeper on 2018-001149-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001149-15.